- Home
- PHAR vs RGR Comparison
PHAR vs RGR Comparison
Compare PHAR & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- RGR
- Stock Information
- Founded
- PHAR 1988
- RGR 1949
- Country
- PHAR Netherlands
- RGR United States
- Employees
- PHAR N/A
- RGR N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- RGR Ordnance And Accessories
- Sector
- PHAR Health Care
- RGR Industrials
- Exchange
- PHAR Nasdaq
- RGR Nasdaq
- Market Cap
- PHAR 618.3M
- RGR 610.8M
- IPO Year
- PHAR N/A
- RGR N/A
- Fundamental
- Price
- PHAR $8.20
- RGR $35.60
- Analyst Decision
- PHAR Strong Buy
- RGR
- Analyst Count
- PHAR 3
- RGR 0
- Target Price
- PHAR $27.00
- RGR N/A
- AVG Volume (30 Days)
- PHAR 5.6K
- RGR 126.1K
- Earning Date
- PHAR 03-13-2025
- RGR 02-19-2025
- Dividend Yield
- PHAR N/A
- RGR 1.94%
- EPS Growth
- PHAR N/A
- RGR N/A
- EPS
- PHAR N/A
- RGR 1.73
- Revenue
- PHAR $285,745,000.00
- RGR $520,485,000.00
- Revenue This Year
- PHAR $20.08
- RGR N/A
- Revenue Next Year
- PHAR $9.22
- RGR $4.81
- P/E Ratio
- PHAR N/A
- RGR $20.50
- Revenue Growth
- PHAR 30.64
- RGR N/A
- 52 Week Low
- PHAR $6.65
- RGR $34.11
- 52 Week High
- PHAR $13.20
- RGR $48.20
- Technical
- Relative Strength Index (RSI)
- PHAR 36.29
- RGR 47.22
- Support Level
- PHAR $8.49
- RGR $34.98
- Resistance Level
- PHAR $9.35
- RGR $36.57
- Average True Range (ATR)
- PHAR 0.55
- RGR 0.70
- MACD
- PHAR -0.17
- RGR 0.03
- Stochastic Oscillator
- PHAR 12.14
- RGR 30.24
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.